A Phase I/IIa Sporozoite Challenge Study to Assess the Safety, Immunogenicity and Protective Efficacy of Intravenous Boosting With Malaria Vaccine Candidates ChAd63 and MVA Encoding ME-TRAP
Phase of Trial: Phase I/II
Latest Information Update: 27 Sep 2019
Price : $35 *
At a glance
- Drugs ME-TRAP malaria DNA vaccine Okairos (Primary) ; ME-TRAP malaria DNA vaccine Okairos (Primary)
- Indications Malaria
- Focus Adverse reactions; Therapeutic Use
- 25 Sep 2019 Status changed from active, no longer recruiting to completed.
- 25 Jul 2019 Planned primary completion date changed from 1 Jun 2020 to 1 Jan 2020.
- 26 Feb 2019 Planned primary completion date changed from 1 Jan 2020 to 1 Jun 2020.